This inventor holds 2 USPTO granted patents. Top assignee: Alcon Laboratories, Inc.. Active years: 1986-1993.
Company Filing History:
Years Active: 1986-1993
Title: Joseph M DeFaller: Innovator in Ocular Health
Introduction
Joseph M DeFaller is a notable inventor based in Bedford, TX (US), recognized for his contributions to ocular health. He holds 2 patents that focus on innovative methods for controlling intraocular pressure and ocular bleeding, utilizing clonidine derivatives.
Latest Patents
His latest patents include "Control of post-surgical intraocular pressure using clonidine derivatives," which describes a method for managing intraocular pressure through nonchronic, topical administration of a clonidine derivative immediately before and after trauma to the affected eye. Another significant patent is "Control of ocular bleeding using clonidine derivatives," which outlines a method for controlling anterior segment ocular bleeding by employing various clonidine derivatives, such as p-aminoclonidine, as a hemostatic agent.
Career Highlights
Joseph M DeFaller is currently associated with Alcon Laboratories, Inc., where he continues to advance research in ocular health. His work has significantly impacted the field, providing new solutions for patients undergoing eye surgeries.
Collaborations
He has collaborated with notable coworkers, including Billie M York and Louis M Desantis, Jr., contributing to a dynamic research environment focused on innovative ocular treatments.
Conclusion
Joseph M DeFaller's work exemplifies the intersection of innovation and healthcare, particularly in the field of ophthalmology. His patents reflect a commitment to improving patient outcomes through advanced medical techniques.